These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27547051)

  • 1. Hair loss and regeneration performed on animal models.
    Orasan MS; Roman II; Coneac A; Muresan A; Orasan RI
    Clujul Med; 2016; 89(3):327-34. PubMed ID: 27547051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the treatment of male pattern hair loss.
    York K; Meah N; Bhoyrul B; Sinclair R
    Expert Opin Pharmacother; 2020 Apr; 21(5):603-612. PubMed ID: 32066284
    [No Abstract]   [Full Text] [Related]  

  • 3. Androgenetic alopecia: an evidence-based treatment update.
    Varothai S; Bergfeld WF
    Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration.
    Zhang P; Kling RE; Ravuri SK; Kokai LE; Rubin JP; Chai JK; Marra KG
    J Tissue Eng; 2014; 5():2041731414556850. PubMed ID: 25383178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of minoxidil in the hair transplantation setting.
    Avram MR; Cole JP; Gandelman M; Haber R; Knudsen R; Leavitt MT; Leonard RT; Puig CJ; Rose PT; Vogel JE; Ziering CL;
    Dermatol Surg; 2002 Oct; 28(10):894-900; discussion 900. PubMed ID: 12410672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viable terminal scalp hair follicles constitute a necessary and sufficient biological end-organ that conditions clinical efficacy of finasteride in males with male pattern hair loss without implying reversal of miniaturized follicles.
    Van Neste D
    Skin Res Technol; 2019 Sep; 25(5):701-711. PubMed ID: 31206839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil therapy for hair regrowth.
    Rumsfield JA; West DP; Fiedler-Weiss VC
    Clin Pharm; 1987 May; 6(5):386-92. PubMed ID: 3311578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical minoxidil for hair regrowth.
    Vanderveen EE; Ellis CN; Kang S; Case P; Headington JT; Voorhees JJ; Swanson NA
    J Am Acad Dermatol; 1984 Sep; 11(3):416-21. PubMed ID: 6384289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions for female pattern hair loss.
    van Zuuren EJ; Fedorowicz Z; Carter B; Andriolo RB; Schoones J
    Cochrane Database Syst Rev; 2012 May; (5):CD007628. PubMed ID: 22592723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hair follicle biology and topical minoxidil: possible mechanisms of action.
    Headington JT
    Dermatologica; 1987; 175 Suppl 2():19-22. PubMed ID: 3319729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Mesenchymal Stem Cell-Derived Conditioned Media for Hair Regeneration Applications.
    Ramdasi S; Tiwari SK
    J Stem Cells; 2016; 11(4):201-211. PubMed ID: 28296872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
    Sinclair R; Patel M; Dawson TL; Yazdabadi A; Yip L; Perez A; Rufaut NW
    Br J Dermatol; 2011 Dec; 165 Suppl 3():12-8. PubMed ID: 22171680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler laser imaging predicts response to topical minoxidil in the treatment of female pattern hair loss.
    McCoy J; Kovacevic M; Situm M; Stanimirovic A; Bolanca Z; Goren A
    J Biol Regul Homeost Agents; 2016; 30(1):131-4. PubMed ID: 27049083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
    Suchonwanit P; Iamsumang W; Rojhirunsakool S
    Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
    Hamada K; Randall VA
    Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
    Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
    J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
    Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
    J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.